‘Normalizing’ the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin

Reestablishing tissue organization of breast cancer cells into acini was previously shown to override their malignant phenotype. In our study, we demonstrate that alpha(v)beta(3) integrin (Int-αvβ3), previously shown to play a role in cancer progression, promoted differentiation and growth arrest of...

Full description

Saved in:
Bibliographic Details
Main Authors: Abu-Tayeh, Hanan (Author) , Thaler, Sonja (Author) , Sleeman, Jonathan P. (Author)
Format: Article (Journal)
Language:English
Published: 1 December 2016
In: Cell death & disease
Year: 2016, Volume: 7, Issue: 12
ISSN:2041-4889
DOI:10.1038/cddis.2016.387
Online Access:Verlag, Volltext: http://dx.doi.org/10.1038/cddis.2016.387
Verlag, Volltext: http://www.nature.com/articles/cddis2016387
Get full text
Author Notes:Hanan Abu-Tayeh, Keren Weidenfeld, Alisa Zhilin-Roth, Sagi Schif-Zuck, Sonja Thaler, Cristina Cotarelo, Tuan Z. Tan, Jean P. Thiery, Jeffrey E. Green, Geula Klorin, Edmond Sabo, Jonathan P. Sleeman, Maty Tzukerman and Dalit Barkan
Description
Summary:Reestablishing tissue organization of breast cancer cells into acini was previously shown to override their malignant phenotype. In our study, we demonstrate that alpha(v)beta(3) integrin (Int-αvβ3), previously shown to play a role in cancer progression, promoted differentiation and growth arrest of organoids derived from luminal A breast cancer cells grown in their relevant three-dimensional microenvironment. These organoids differentiated into normal-like acini resembling a benign stage of breast tissue. Likewise, we demonstrate that Int-αvβ3 is selectively expressed in the epithelium of the benign stage of breast tissues, and is lost during the early stages of luminal A breast cancer progression. Notably, the organoids’ reversion into normal-like acini was mediated by cancer luminal progenitor-like cells expressing both EpCAMhighCD49flowCD24+ and Int-αvβ3. Furthermore, downregulation of Notch4 expression and downstream signaling was shown to mediate Int-αvβ3-induced reversion. Intriguingly, when luminal A breast cancer cells expressing Int-αvβ3 were injected into a humanized mouse model, differentiated tumors developed when compared with that generated by control cells. Hence, our data suggest that promoting differentiation of luminal A breast cancer cells by signaling emanating from Int-αvβ3 can potentially promote ‘normalization’ of their malignant phenotype and may prevent the malignant cells from progressing.
Item Description:Gesehen am 26.02.2019
Physical Description:Online Resource
ISSN:2041-4889
DOI:10.1038/cddis.2016.387